1. Home
  2. AQMS vs SNGX Comparison

AQMS vs SNGX Comparison

Compare AQMS & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aqua Metals Inc.

AQMS

Aqua Metals Inc.

HOLD

Current Price

$4.24

Market Cap

13.9M

Sector

Industrials

ML Signal

HOLD

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$1.19

Market Cap

12.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AQMS
SNGX
Founded
2014
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.9M
12.3M
IPO Year
2015
2006

Fundamental Metrics

Financial Performance
Metric
AQMS
SNGX
Price
$4.24
$1.19
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$12.00
$6.00
AVG Volume (30 Days)
28.0K
108.0K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,100,000.00
$119,371.00
Revenue This Year
N/A
N/A
Revenue Next Year
$550.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$1.02
52 Week High
$39.37
$6.23

Technical Indicators

Market Signals
Indicator
AQMS
SNGX
Relative Strength Index (RSI) 34.84 48.05
Support Level $4.01 $1.16
Resistance Level $4.47 $1.22
Average True Range (ATR) 0.28 0.07
MACD -0.05 0.01
Stochastic Oscillator 8.72 43.48

Price Performance

Historical Comparison
AQMS
SNGX

About AQMS Aqua Metals Inc.

Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: